Endocrine Society Submitted Testimony to the Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee
"The Society urges the FDA to give fair consideration of new options in combating this disease and to expedite the approval process for emerging therapies that, based on safety and efficacy data, have the potential to reduce complications and impact the progression of diabetes. "
Read the Full Testimony
We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.